1. Aguglia E (2000) Reboxetine in the maintenance therapy of depressive disorder in the elderly: a long-term open study. Int J Geriatr Psychiatry 15:784–793
2. Ahronheim J (1993) Practical pharmacology for older patients: avoiding adverse drug effects. The Mount Sinai Journal of Medicine 60:497–501
3. Alexopoulos GS, Katz IR, Reynolds CF, Carpenter D, Docherty JP. The expert consensus guideline series: pharmacotherapy of depressive disorders in older patients. Postgraduate Medicine Special Report 2001;October: 1–86
4. Altamura AC, Mauri MC, Rudas N, Carpiniello B, Montanini R, Perini M, Scapicchio PL, Hadjchristos C, Carucci G, Minervini M, et al (1989) Clinical activity and tolerability of trazodone, mianserin, and amitriptyline in elderly subjects with major depression: a controlled multicenter trial. Clin Neuropharmacology 12(suppl 1):S25–S33
5. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, fourth edition. American Psychiatric Association, Washington, DC